Applied Spectral Imaging recently launched its GenASIs Go-Path computer-aided membrane and nuclear immunohistochemistry imaging and analysis platform.
Go-Path features ASI’s point-of-view pathology imaging and analysis. The Go-Path instrument allows users to adopt a point-acquire-score workflow. Users simply target a cancer region under the microscope, hit a button to capture an image, and automatically receive a computer-generated scoring map to aid in scoring. Go-Path makes immunohistochemistry scoring quick, accurate, and repeatable, enhancing the quality and consistency of the results.
Go-Path is not FDA cleared for clinical use and is for research use only. GenASIs is FDA cleared for FISH clinical applications such as UroVysion, HER2/neu, CEP XY, and karyotyping. ASI complies with major regulatory requirements and international quality standards.
Applied Spectral Imaging, 800-611-3466